R&D
| Product Name | R&D Code | Product Description | Indication | Development Stage |
|---|---|---|---|---|
| PS1 | PS-001 | Small Molecule Drug (Tablet) | Type 2 Diabetes |
Phase I Part Ib Clinical Trial (Ongoing) Phase II Clinical Trial (In Planning) |
| PS-002 | Small Molecule Drug (Tablet) | Type 1 Diabetes | Phase II Clinical Trial (In Planning) | |
| PS-003 | Small Molecule Drug (Tablet) | Other | Development in Progress |
News
- [NEWS] New Force in New Drug Stocks! Pharmasaga to List on Emerging Stock Market on the 27th at Reference Price of NT$120
- [NEWS] Pharmasaga's Innovative Drug for Type 1/2 Diabetes Plans Phase II, Creates Buzz Ahead of Emerging Stock Listing
- [NEWS] Pharmasaga Wins 2025 Taipei Biotech Award - Innovative Technology Award
- [NEWS] Pharmasaga Competes for the North America BIO Convention Startup Competition Championship
- [2025] Pharmasaga's Innovative Diabetes Drug PS1 Demonstrates Curative Potential, Initiates Taiwan-US Clinical Trials
- [2025] Taiwan Participates in BIO 2025 North America Biotech Exhibition: Dual Focus on All-Age Healthcare Layout and International Connections
Contact Us
- Pharmasaga
- Phone number : + 886-2-27938665
- E-mail : contact@pharmasaga.com
- Address : 22 F.-1, No. 93, Sec. 1, Xintai 5th Rd., Xizhi Dist., New Taipei City 221416, Taiwan (R.O.C.)